4-[3-(4-fluorophenyl)-1H-pyrazol-5-yl]-1-[[1-[4-(trifluoromethyl)phenyl]pyrrol-3-yl]methyl]piperidine
C26H24F4N4 — CID 44562563
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[3-(4-fluorophenyl)-1H-pyrazol-5-yl]-1-[[1-[4-(trifluoromethyl)phenyl]pyrrol-3-yl]methyl]piperidine
4-[3-(4-fluorophenyl)-1H-pyrazol-5-yl]-1-[[1-[4-(trifluoromethyl)phenyl]pyrrol-3-yl]methyl]piperidine (PubChem CID 44562563) has the molecular formula C26H24F4N4 and a molecular weight of 468.50 g/mol. Its IUPAC name is 4-[3-(4-fluorophenyl)-1H-pyrazol-5-yl]-1-[[1-[4-(trifluoromethyl)phenyl]pyrrol-3-yl]methyl]piperidine.
Molecular Properties
| Compound Name | 4-[3-(4-fluorophenyl)-1H-pyrazol-5-yl]-1-[[1-[4-(trifluoromethyl)phenyl]pyrrol-3-yl]methyl]piperidine |
|---|---|
| PubChem CID | 44562563 |
| Molecular Formula | C26H24F4N4 |
| Molecular Weight | 468.50 g/mol |
| Exact Mass | 468.19 |
| IUPAC Name | 4-[3-(4-fluorophenyl)-1H-pyrazol-5-yl]-1-[[1-[4-(trifluoromethyl)phenyl]pyrrol-3-yl]methyl]piperidine |
| SMILES | Fc1ccc(-c2cc(C3CCN(Cc4ccn(-c5ccc(C(F)(F)F)cc5)c4)CC3)[nH]n2)cc1 |
| InChI | InChI=1S/C26H24F4N4/c27-22-5-1-19(2-6-22)24-15-25(32-31-24)20-10-12-33(13-11-20)16-18-9-14-34(17-18)23-7-3-21(4-8-23)26(28,29)30/h1-9,14-15,17,20H,10-13,16H2,(H,31,32) |
| InChIKey | IVFPBVVRSLWLAX-UHFFFAOYSA-N |
| XLogP | 6.40 |
| TPSA | 36.85 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 468.50 |
| LogP ≤ 5 | 6.40 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 44562563 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.